N0050000

Nalidixinsäure

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): 1,4-Dihydro-1-ethyl-7-methyl-1,8-naphthyridin-4-on-3-carbonsäure, 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridin-3-carbonsäure
• Empirische Formel (Hill-System): C₁₂H₁₂N₂O₃
• CAS-Nummer: 389-08-2
• Molekulargewicht: 232.24
• Beilstein: 750515
• MDL-Nummer: MFCD00006884
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329818394
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: nalidixic acid
• Hersteller/Markenname: EDQM
• mp (Schmelzpunkt): 227-229 °C (lit.)
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: CCN1C=C(C(O)=O)C(=O)c2ccc(C)nc12
• InChI: 1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)
• InChIKey: MHWLWQUZZRMNGJ-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Nalidixic acid EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07
• Signalwort: Warning
• H-Sätze: H302,H351
• P-Sätze: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• Gefahreneinstufungen: Acute Tox. 4 Oral - Carc. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable